HK1071376A1 - Methylene-4-azasteroids - Google Patents

Methylene-4-azasteroids

Info

Publication number
HK1071376A1
HK1071376A1 HK05104308A HK05104308A HK1071376A1 HK 1071376 A1 HK1071376 A1 HK 1071376A1 HK 05104308 A HK05104308 A HK 05104308A HK 05104308 A HK05104308 A HK 05104308A HK 1071376 A1 HK1071376 A1 HK 1071376A1
Authority
HK
Hong Kong
Prior art keywords
sup
methylene
denote
hydrogen atom
denotes
Prior art date
Application number
HK05104308A
Other languages
English (en)
Inventor
Bernd Menzenbach
Peter Droescher
Alexander Hillisch
Walter Elger
Hans-Udo Schweikert
Klaus Schoellkopf
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HK1071376A1 publication Critical patent/HK1071376A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK05104308A 2001-08-28 2005-05-24 Methylene-4-azasteroids HK1071376A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141984A DE10141984A1 (de) 2001-08-28 2001-08-28 Neue 17-Methylen-4-azasteroide
PCT/EP2002/009587 WO2003020744A1 (fr) 2001-08-28 2002-08-28 Methylene-4-azasteroides

Publications (1)

Publication Number Publication Date
HK1071376A1 true HK1071376A1 (en) 2005-07-15

Family

ID=7696782

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104308A HK1071376A1 (en) 2001-08-28 2005-05-24 Methylene-4-azasteroids

Country Status (22)

Country Link
US (1) US7186728B2 (fr)
EP (1) EP1409513B1 (fr)
JP (1) JP3927174B2 (fr)
KR (1) KR100550514B1 (fr)
CN (1) CN1322002C (fr)
AT (1) ATE323100T1 (fr)
AU (1) AU2002342625B8 (fr)
BR (1) BR0212104A (fr)
CA (1) CA2458932C (fr)
CY (1) CY1105083T1 (fr)
DE (2) DE10141984A1 (fr)
DK (1) DK1409513T3 (fr)
ES (1) ES2262856T3 (fr)
HK (1) HK1071376A1 (fr)
HU (1) HUP0401597A3 (fr)
IL (2) IL160540A0 (fr)
NO (1) NO326564B1 (fr)
PL (1) PL367460A1 (fr)
PT (1) PT1409513E (fr)
RU (1) RU2293740C2 (fr)
WO (1) WO2003020744A1 (fr)
ZA (1) ZA200402368B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110628735B (zh) * 2019-04-23 2022-04-08 天津科技大学 一种5α-还原酶突变体，基因工程菌及其在高效催化5α-AD生产中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
JPH11513711A (ja) * 1995-10-23 1999-11-24 メルク エンド カンパニー インコーポレーテッド １７−アルキル−７−置換−４−アザステロイド誘導体
US5763361A (en) * 1995-10-23 1998-06-09 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors
US5994334A (en) * 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
WO2002000681A1 (fr) * 2000-06-27 2002-01-03 Aventis Pharma S.A. Steroïdes 20-fluoro-17(20)-vinyliques convenant comme inhibiteurs ce la c17-20-lyase et de la 5-alpha reductase
DE10043846A1 (de) * 2000-09-04 2002-04-04 Jenapharm Gmbh 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
US7186728B2 (en) 2007-03-06
KR20040032978A (ko) 2004-04-17
IL160540A0 (en) 2004-07-25
RU2293740C2 (ru) 2007-02-20
AU2002342625B8 (en) 2009-01-08
ES2262856T3 (es) 2006-12-01
CY1105083T1 (el) 2009-11-04
US20040248921A1 (en) 2004-12-09
WO2003020744A1 (fr) 2003-03-13
DK1409513T3 (da) 2006-08-14
PT1409513E (pt) 2006-08-31
CN1549822A (zh) 2004-11-24
PL367460A1 (en) 2005-02-21
JP2005504786A (ja) 2005-02-17
IL160540A (en) 2009-11-18
JP3927174B2 (ja) 2007-06-06
ATE323100T1 (de) 2006-04-15
HUP0401597A2 (hu) 2004-12-28
AU2002342625B2 (en) 2008-12-04
HUP0401597A3 (en) 2011-02-28
KR100550514B1 (ko) 2006-02-13
EP1409513A1 (fr) 2004-04-21
BR0212104A (pt) 2004-08-24
EP1409513B1 (fr) 2006-04-12
CN1322002C (zh) 2007-06-20
CA2458932A1 (fr) 2003-03-13
NO20041279L (no) 2004-03-26
ZA200402368B (en) 2005-05-20
NO326564B1 (no) 2009-01-12
CA2458932C (fr) 2008-07-22
RU2004109166A (ru) 2005-10-10
DE10141984A1 (de) 2003-03-20
DE50206397D1 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
MXPA03011006A (es) Compuestos de cicloalquil urea benzo-fusionados 1,4-disustituidos.
MXPA04001203A (es) 1-h-pirido[4,3-b] indoles terapeuticos.
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
YU63703A (sh) 6-supstituisani pirido-pirimidini
MY125942A (en) Aminoalkoxy carbazoles for the treatment of cns diseases
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
IL145164A0 (en) Substituted aniline compounds
MY138263A (en) Therapeutic chroman compounds
NO20002676D0 (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
DE60128003D1 (en) Camptothecin derivate
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
IL159931A0 (en) Process for producing pyridine compound
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
EA200100040A1 (ru) Химический синтез морфолиновых производных
HK1071376A1 (en) Methylene-4-azasteroids
PT1204659E (pt) Benzofuranos serotoninergicos
GB0130577D0 (en) Method of monitoring/controlling thysanoptera
IL156768A0 (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
IL138638A0 (en) Processes for preparing intermediates
HU0201262D0 (fr)
ATE319708T1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als fungizide
ES2184628A1 (es) Procedimiento estereoselectivo para la produccion de 6 -fluorpregnanos e intermedios.
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
IL153412A0 (en) Method for producing 4-bromine aniline derivatives
IL158530A0 (en) Method for producing 1,3-disubstituted 2-nitroguanidines

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110828